372: A pharma C-suite shakeup and Trump's deal with Pfizer

32:29 | Oct 2nd

How will we look back on Emma Walmsley's tenure as GSK's CEO? Why did one of the FDA's top drug officials call out an obscure lupus drug on LinkedIn? And will we ever stop talking about the pharma pat...Show More